adenine has been researched along with Osteomalacia in 48 studies
Osteomalacia: Disorder caused by an interruption of the mineralization of organic bone matrix leading to bone softening, bone pain, and weakness. It is the adult form of rickets resulting from disruption of VITAMIN D; PHOSPHORUS; or CALCIUM homeostasis.
Excerpt | Relevance | Reference |
---|---|---|
" He had been receiving low-dose adefovir dipivoxil (ADV) for the treatment of lamivudine-resistant chronic hepatitis B virus infection for eight years and subsequently developed severe hypophosphatemia and proximal renal tubule dysfunction." | 8.90 | Hypophosphatemic osteomalacia due to drug-induced Fanconi's syndrome associated with adefovir dipivoxil treatment for hepatitis B. ( Eguchi, H; Hiromatsu, Y; Kuwahara, R; Tani, J; Tsuruta, M, 2014) |
"Adefovir dipivoxil induced hypophosphataemic osteomalacia is rarely seen in clinical practice." | 8.87 | [A case of adefovir dipivoxil induced hypophosphataemic osteomalacia and literature review]. ( Li, XP; Meng, XW; Sun, XF; Xia, WB; Xing, XP; Zhang, HB, 2011) |
"Adefovir dipivoxil (ADV) is one of the most important nucleostide analogues currently in use for the treatment of chronic hepatitis B virus (HBV) infection." | 7.91 | Low-dose adefovir dipivoxil-induced hypophosphatemia osteomalacia in five chronic hepatitis B virus-infected patients. Is low-dose adefovir dipivoxil-induced nephrotoxicity completely reversible? ( Dai, ZJ; Jin, J; Pan, YJ; Qian, YY; Ruan, LY; Shi, MT; Wu, CM; Zhu, YX, 2019) |
" He had been receiving adefovir dipivoxil (ADV) for the treatment of entecavir (ETV)-resistant chronic hepatitis B (CHB) for four years in his 8-year treatment of hepatocellular carcinoma (HCC), but was referred to our hospital after increased levels of bone pain in his ribs, knees, and ankles." | 7.91 | [Adefovir Dipivoxil-induced Fanconi's Syndrome and Osteomalacia Following Multiple Bone Fractures in a Patient with Chronic Hepatitis B]. ( Ikeda, A; Ikeda, F; Kanzaki, H; Kitamura, Y; Makita, T; Murakawa, K; Nishihara, S; Okada, H; Onishi, H; Sendo, T; Shiraha, H; Takaki, A; Takeuchi, Y; Tanaka, Y; Wada, N; Yasunaka, T, 2019) |
" She had a 7-year history of taking adefovir at 10 mg/day for chronic hepatitis B." | 7.88 | Adefovir-induced Fanconi syndrome associated with osteomalacia. ( Cha, SK; Cho, DH; Kim, HS; Kim, JH; Kim, WI; Kim, YJ; Lee, EY; Lee, JH; Lee, SM; Park, KS; Park, S, 2018) |
"To investigate the predictors of hypophosphatemic osteomalacia induced by adefovir dipivoxil (ADV) and to monitor for early detection." | 7.88 | Clinical features of hypophosphatemic osteomalacia induced by long-term low-dose adefovir dipivoxil. ( Feng, L; Gao, RW; Li, R; Yang, YH; Zhang, B; Zhu, S; Zou, YZ, 2018) |
"Retrieval of case reports was based on Pubmed, CNKI, Wan Fang and VIP databases using the key words adefovir dipivoxil, hypophosphatemia, osteomalacia and Fanconi syndrome." | 7.88 | Adefovir dipivoxil induced hypophosphatemic osteomalacia in chronic hepatitis B: a comparative study of Chinese and foreign case series. ( Chen, N; Li, LY; Liu, LW; Peng, T; Tang, KX; Yu, F; Yu, X; Zhang, JB; Zhang, Q; Zhao, YP, 2018) |
"Adefovir-induced hypophosphatemic osteomalacia in the context of hepatocarcinoma is rare and needs to be differentiated from metastatic hepatocarcinoma." | 7.85 | Adefovir-Induced Hypophosphatemic Osteomalacia Mimicking Bone Metastases From Primary Hepatocarcinoma. ( Luo, QY; Qiu, ZL; Shen, CT; Sun, ZK; Wei, WJ, 2017) |
"An increasing number of case reports suggest that acquired renal Fanconi syndrome may be associated with prolonged use of adefovir against hepatitis B virus." | 7.85 | Nephrolithiasis and Osteomalacia associated with adefovir-induced Fanconi syndrome in a patient with hepatitis B. ( Lin, J; Zhang, D; Zhuo, Y, 2017) |
"Adefovir dipivoxil (ADV) was an important cause of adult-onset hypophosphatemic osteomalacia." | 7.83 | Osteomalacia induced by long-term low-dose adefovir dipivoxil: Clinical characteristics and genetic predictors. ( Fu, WZ; He, JW; Wei, Z; Zhang, ZL, 2016) |
"Adefovir dipivoxil (ADV) is effective for hepatitis B virus (HBV) infection; however, ADV may provoke renal injury resulting in osteomalacia, and this side effect is seldom recognized until bone fractures emerge." | 7.83 | Urinary β-2 Microglobulin Levels Sensitively Altered in an Osteomalacia Patient Receiving Add-on Adefovir Dipivoxil Therapy for Hepatitis B Virus Infection. ( Hirase, S; Ito, K; Ito, T; Morishima, T; Morita, H; Ohashi, T; Otake, K; Takagi, J; Yoneda, M, 2016) |
"In human immunodeficiency virus (HIV)-infected patients, tenofovir disoproxil fumarate (TDF) may cause hypophosphatemia leading to osteomalacia due to renal phosphate wasting." | 7.80 | Fibroblast growth factor 23 is elevated in tenofovir-related hypophosphatemia. ( Holmes, DT; Jiang, SY; Kendler, DL; Saeedi, R, 2014) |
"A 64-year-old woman was prescribed lamivudine and adefovir (ADV) for chronic hepatitis B." | 7.80 | [A case of chronic hepatitis B managed with continued adefovir despite treatment-related Fanconi syndrome and osteomalacia]. ( Asahina, Y; Iizuka, K; Iizuka, Y; Ito, E; Kobayashi, K; Mochizuki, N; Sakai, H; Watanabe, M, 2014) |
"Occurrence of hypophosphatemic osteomalacia (HO) induced by administration of low-dose adefovir therapy is rare, and bone scintigraphy of the disease has rarely been reported." | 7.79 | Bone scintigraphic findings of hypophosphatemic osteomalacia associated with adefovir therapy: involvement of lower extremity skeletons. ( Ahn, BC; Kim, DH; Kweon, YO; Lee, J; Lee, SW, 2013) |
"We present a case of a 62-year-old man who underwent total hip arthroplasty for treatment of pathologic femoral neck fracture associated with adefovir dipivoxil-induced osteomalacia." | 7.78 | Pathological femoral fractures due to osteomalacia associated with adefovir dipivoxil treatment for hepatitis B: a case report. ( Arishima, Y; Hirotsu, M; Ishidou, Y; Kakoi, H; Kamizono, J; Komiya, S; Nagano, S; Nakamura, S; Saitoh, Y; Setoguchi, T; Tanaka, M; Yokouchi, M, 2012) |
"We present 2 human immunodeficiency virus-infected patients with tenofovir disoproxil fumarate-induced Fanconi syndrome, leading to osteomalacia." | 7.77 | Tenofovir-induced Fanconi syndrome and osteomalacia in two HIV-infected patients: role of intracellular tenofovir diphosphate levels and review of the literature. ( Bronsveld, W; Haverkort, ME; Huitema, AD; Lips, P; Slieker, WA; ter Heine, R; van der Spek, BW, 2011) |
"The antiretroviral agent tenofovir can cause hypophosphatemic osteomalacia due to renal phosphate wasting." | 7.77 | Normal plasma FGF23 levels kinetic in tenofovir-related hypophosphatemic osteomalacia in an HIV-infected patient with von Recklinghausen disease. ( Boissier, MC; Prendki, V; Prie, D; Saidenberg-Kermanac'h, N; Souabni, L, 2011) |
"Adefovir dipivoxil is commonly used for treatment of chronic hepatitis B." | 7.77 | [Adefovir dipivoxil-induced Fanconi syndrome and hypophosphatemic osteomalacia associated with muscular weakness in a patient with chronic hepatitis B]. ( Dong, GF; Li, L; Xie, YS; Zhang, X, 2011) |
"We report two cases in which osteomalacia developed in patients on tenofovir-containing highly active antiretroviral therapy (HAART) in the context of Fanconi syndrome with hypophosphataemia." | 7.73 | The development of hypophosphataemic osteomalacia with myopathy in two patients with HIV infection receiving tenofovir therapy. ( Issa, BG; Parsonage, MJ; Savage, MW; Snowden, N; Wilkins, EG, 2005) |
"Osteomalacia is a metabolic bone disease that leads to softening of the bones and can be caused by hypophosphatemia." | 6.49 | Hypophosphatemic osteomalacia induced by low-dose adefovir therapy: focus on manifestations in the skeletal system and literature review. ( Kim, du H; Min, YK; Sung, DH, 2013) |
"Fanconi syndrome with osteomalacia can develop in patients with chronic hepatitis B infection being treated with adefovir at a conventional low dosage of 10 mg/day." | 5.56 | Osteomalacia and renal failure due to Fanconi syndrome caused by long-term low-dose Adefovir Dipivoxil: a case report. ( Cen, X; Cui, Y; Liu, Z; Mu, G; Xiang, Q; Xie, Q; Yu, Y; Zhang, H; Zhang, J, 2020) |
"This case indicates that Fanconi's syndrome with osteomalacia can be acquired by a chronic hepatitis B patient taking ADV at a conventional dosage of 10 mg/day." | 5.42 | Osteomalacia and Fanconi's syndrome caused by long-term low-dose adefovir dipivoxil. ( Chen, YS; Sun, FR; Wang, BF; Wang, BY; Wang, Y; Zhang, D, 2015) |
"Hypophosphatemic osteomalacia and renal Fanconi syndrome can be associated with low-dose ADV." | 5.39 | Hypophosphatemic osteomalacia and renal Fanconi syndrome induced by low-dose adefovir dipivoxil: a case report and literature review suggesting ethnic predisposition. ( Dai, Z; Gu, X; Qian, Y; Wang, L; Wu, C; Zhang, H, 2013) |
" He had been receiving low-dose adefovir dipivoxil (ADV) for the treatment of lamivudine-resistant chronic hepatitis B virus infection for eight years and subsequently developed severe hypophosphatemia and proximal renal tubule dysfunction." | 4.90 | Hypophosphatemic osteomalacia due to drug-induced Fanconi's syndrome associated with adefovir dipivoxil treatment for hepatitis B. ( Eguchi, H; Hiromatsu, Y; Kuwahara, R; Tani, J; Tsuruta, M, 2014) |
"Adefovir dipivoxil induced hypophosphataemic osteomalacia is rarely seen in clinical practice." | 4.87 | [A case of adefovir dipivoxil induced hypophosphataemic osteomalacia and literature review]. ( Li, XP; Meng, XW; Sun, XF; Xia, WB; Xing, XP; Zhang, HB, 2011) |
" He had been receiving adefovir dipivoxil (ADV) for the treatment of entecavir (ETV)-resistant chronic hepatitis B (CHB) for four years in his 8-year treatment of hepatocellular carcinoma (HCC), but was referred to our hospital after increased levels of bone pain in his ribs, knees, and ankles." | 3.91 | [Adefovir Dipivoxil-induced Fanconi's Syndrome and Osteomalacia Following Multiple Bone Fractures in a Patient with Chronic Hepatitis B]. ( Ikeda, A; Ikeda, F; Kanzaki, H; Kitamura, Y; Makita, T; Murakawa, K; Nishihara, S; Okada, H; Onishi, H; Sendo, T; Shiraha, H; Takaki, A; Takeuchi, Y; Tanaka, Y; Wada, N; Yasunaka, T, 2019) |
"Adefovir dipivoxil (ADV) is one of the most important nucleostide analogues currently in use for the treatment of chronic hepatitis B virus (HBV) infection." | 3.91 | Low-dose adefovir dipivoxil-induced hypophosphatemia osteomalacia in five chronic hepatitis B virus-infected patients. Is low-dose adefovir dipivoxil-induced nephrotoxicity completely reversible? ( Dai, ZJ; Jin, J; Pan, YJ; Qian, YY; Ruan, LY; Shi, MT; Wu, CM; Zhu, YX, 2019) |
"Adefovir dipivoxil is a nucleotide analogue that is approved for treatment of chronic hepatitis B." | 3.91 | Denosumab improves clinical manifestations of hypophosphatemic osteomalacia by adefovir-induced Fanconi syndrome: a case report. ( Aso, Y; Iijima, T; Jojima, T; Kase, M; Kogai, T; Kunii, T; Sakurai, S; Shimizu, M; Usui, I, 2019) |
"Retrieval of case reports was based on Pubmed, CNKI, Wan Fang and VIP databases using the key words adefovir dipivoxil, hypophosphatemia, osteomalacia and Fanconi syndrome." | 3.88 | Adefovir dipivoxil induced hypophosphatemic osteomalacia in chronic hepatitis B: a comparative study of Chinese and foreign case series. ( Chen, N; Li, LY; Liu, LW; Peng, T; Tang, KX; Yu, F; Yu, X; Zhang, JB; Zhang, Q; Zhao, YP, 2018) |
"To investigate the predictors of hypophosphatemic osteomalacia induced by adefovir dipivoxil (ADV) and to monitor for early detection." | 3.88 | Clinical features of hypophosphatemic osteomalacia induced by long-term low-dose adefovir dipivoxil. ( Feng, L; Gao, RW; Li, R; Yang, YH; Zhang, B; Zhu, S; Zou, YZ, 2018) |
" She had a 7-year history of taking adefovir at 10 mg/day for chronic hepatitis B." | 3.88 | Adefovir-induced Fanconi syndrome associated with osteomalacia. ( Cha, SK; Cho, DH; Kim, HS; Kim, JH; Kim, WI; Kim, YJ; Lee, EY; Lee, JH; Lee, SM; Park, KS; Park, S, 2018) |
"An increasing number of case reports suggest that acquired renal Fanconi syndrome may be associated with prolonged use of adefovir against hepatitis B virus." | 3.85 | Nephrolithiasis and Osteomalacia associated with adefovir-induced Fanconi syndrome in a patient with hepatitis B. ( Lin, J; Zhang, D; Zhuo, Y, 2017) |
"Adefovir-induced hypophosphatemic osteomalacia in the context of hepatocarcinoma is rare and needs to be differentiated from metastatic hepatocarcinoma." | 3.85 | Adefovir-Induced Hypophosphatemic Osteomalacia Mimicking Bone Metastases From Primary Hepatocarcinoma. ( Luo, QY; Qiu, ZL; Shen, CT; Sun, ZK; Wei, WJ, 2017) |
"Adefovir dipivoxil (ADV) is effective for hepatitis B virus (HBV) infection; however, ADV may provoke renal injury resulting in osteomalacia, and this side effect is seldom recognized until bone fractures emerge." | 3.83 | Urinary β-2 Microglobulin Levels Sensitively Altered in an Osteomalacia Patient Receiving Add-on Adefovir Dipivoxil Therapy for Hepatitis B Virus Infection. ( Hirase, S; Ito, K; Ito, T; Morishima, T; Morita, H; Ohashi, T; Otake, K; Takagi, J; Yoneda, M, 2016) |
"Adefovir dipivoxil (ADV) was an important cause of adult-onset hypophosphatemic osteomalacia." | 3.83 | Osteomalacia induced by long-term low-dose adefovir dipivoxil: Clinical characteristics and genetic predictors. ( Fu, WZ; He, JW; Wei, Z; Zhang, ZL, 2016) |
" He had been receiving low-dose adefovir dipivoxil (ADV, 10 mg/day) for the treatment of chronic hepatitis B virus infection for 7 years and he subsequently developed severe hypophosphatemia and proximal renal tubule dysfunction." | 3.83 | Pathologic Femoral Neck Fracture Due to Fanconi Syndrome Induced by Adefovir Dipivoxil Therapy for Hepatitis B. ( Dan, J; Kim, BK; Lee, HJ; Lee, YS, 2016) |
"To investigate the predictors of proximal kidney tubular dysfunction (PKTD) induced by adefovir dipivoxil (ADV) treatment for chronic hepatitis B." | 3.81 | Predictors of kidney tubular dysfunction induced by adefovir treatment for chronic hepatitis B. ( Furusyo, N; Harada, Y; Hayashi, J; Hayashi, T; Ihara, T; Ikezaki, H; Murata, M; Ogawa, E; Shimizu, M; Toyoda, K, 2015) |
"In human immunodeficiency virus (HIV)-infected patients, tenofovir disoproxil fumarate (TDF) may cause hypophosphatemia leading to osteomalacia due to renal phosphate wasting." | 3.80 | Fibroblast growth factor 23 is elevated in tenofovir-related hypophosphatemia. ( Holmes, DT; Jiang, SY; Kendler, DL; Saeedi, R, 2014) |
"A 64-year-old woman was prescribed lamivudine and adefovir (ADV) for chronic hepatitis B." | 3.80 | [A case of chronic hepatitis B managed with continued adefovir despite treatment-related Fanconi syndrome and osteomalacia]. ( Asahina, Y; Iizuka, K; Iizuka, Y; Ito, E; Kobayashi, K; Mochizuki, N; Sakai, H; Watanabe, M, 2014) |
" Of all the patients, 15 were diagnosed as tumor-induced HO, 4 were long-term oral adefovir dipivoxil-related HO, 3 were associated with Fanconi syndrome, 2 were related to hyperparathyroidism, while 2 were Sjogren's syndrome complicated with renal tubular acidosis." | 3.80 | [The clinical characteristics of 26 cases of hypophosphatemia osteomalacia misdiagnosed as spondyloarthritis]. ( Feng, L; Huang, F; Jin, J; Luo, G; Ma, H; Sun, F; Wang, G; Wang, Y; Yang, J; Zhang, J; Zhao, W; Zhao, Z; Zhu, J, 2014) |
"Occurrence of hypophosphatemic osteomalacia (HO) induced by administration of low-dose adefovir therapy is rare, and bone scintigraphy of the disease has rarely been reported." | 3.79 | Bone scintigraphic findings of hypophosphatemic osteomalacia associated with adefovir therapy: involvement of lower extremity skeletons. ( Ahn, BC; Kim, DH; Kweon, YO; Lee, J; Lee, SW, 2013) |
"We present a case of a 62-year-old man who underwent total hip arthroplasty for treatment of pathologic femoral neck fracture associated with adefovir dipivoxil-induced osteomalacia." | 3.78 | Pathological femoral fractures due to osteomalacia associated with adefovir dipivoxil treatment for hepatitis B: a case report. ( Arishima, Y; Hirotsu, M; Ishidou, Y; Kakoi, H; Kamizono, J; Komiya, S; Nagano, S; Nakamura, S; Saitoh, Y; Setoguchi, T; Tanaka, M; Yokouchi, M, 2012) |
"The antiretroviral agent tenofovir can cause hypophosphatemic osteomalacia due to renal phosphate wasting." | 3.77 | Normal plasma FGF23 levels kinetic in tenofovir-related hypophosphatemic osteomalacia in an HIV-infected patient with von Recklinghausen disease. ( Boissier, MC; Prendki, V; Prie, D; Saidenberg-Kermanac'h, N; Souabni, L, 2011) |
"We present 2 human immunodeficiency virus-infected patients with tenofovir disoproxil fumarate-induced Fanconi syndrome, leading to osteomalacia." | 3.77 | Tenofovir-induced Fanconi syndrome and osteomalacia in two HIV-infected patients: role of intracellular tenofovir diphosphate levels and review of the literature. ( Bronsveld, W; Haverkort, ME; Huitema, AD; Lips, P; Slieker, WA; ter Heine, R; van der Spek, BW, 2011) |
"Adefovir dipivoxil is commonly used for treatment of chronic hepatitis B." | 3.77 | [Adefovir dipivoxil-induced Fanconi syndrome and hypophosphatemic osteomalacia associated with muscular weakness in a patient with chronic hepatitis B]. ( Dong, GF; Li, L; Xie, YS; Zhang, X, 2011) |
"Adefovir dipivoxil, an acyclic nucleoside analogue, has been approved for the treatment of patients with chronic hepatitis B." | 3.76 | [A case of osteomalacia related to adefovir in a patient with chronic hepatitis B]. ( Ahn, SY; Choe, WH; Choi, YH; Jang, YM; Kim, BK; Ko, SY; Kwon, SY; Lee, CH, 2010) |
"We report two cases in which osteomalacia developed in patients on tenofovir-containing highly active antiretroviral therapy (HAART) in the context of Fanconi syndrome with hypophosphataemia." | 3.73 | The development of hypophosphataemic osteomalacia with myopathy in two patients with HIV infection receiving tenofovir therapy. ( Issa, BG; Parsonage, MJ; Savage, MW; Snowden, N; Wilkins, EG, 2005) |
"Osteomalacia is a metabolic bone disease that leads to softening of the bones and can be caused by hypophosphatemia." | 2.49 | Hypophosphatemic osteomalacia induced by low-dose adefovir therapy: focus on manifestations in the skeletal system and literature review. ( Kim, du H; Min, YK; Sung, DH, 2013) |
"Fanconi syndrome with osteomalacia can develop in patients with chronic hepatitis B infection being treated with adefovir at a conventional low dosage of 10 mg/day." | 1.56 | Osteomalacia and renal failure due to Fanconi syndrome caused by long-term low-dose Adefovir Dipivoxil: a case report. ( Cen, X; Cui, Y; Liu, Z; Mu, G; Xiang, Q; Xie, Q; Yu, Y; Zhang, H; Zhang, J, 2020) |
"A 68-year-old man with type 2 diabetes mellitus and chronic hepatitis B infection was referred to the nephrology department before planned surgery for hepatocellular carcinoma." | 1.51 | Hypophosphatemic Osteomalacia Associated with Adefovir-induced Fanconi Syndrome Initially Diagnosed as Diabetic Kidney Disease and Vitamin D Deficiency. ( Iino, N; Koda, R; Narita, I; Tsuchida, M, 2019) |
"This case indicates that Fanconi's syndrome with osteomalacia can be acquired by a chronic hepatitis B patient taking ADV at a conventional dosage of 10 mg/day." | 1.42 | Osteomalacia and Fanconi's syndrome caused by long-term low-dose adefovir dipivoxil. ( Chen, YS; Sun, FR; Wang, BF; Wang, BY; Wang, Y; Zhang, D, 2015) |
"Hypophosphatemic osteomalacia and renal Fanconi syndrome can be associated with low-dose ADV." | 1.39 | Hypophosphatemic osteomalacia and renal Fanconi syndrome induced by low-dose adefovir dipivoxil: a case report and literature review suggesting ethnic predisposition. ( Dai, Z; Gu, X; Qian, Y; Wang, L; Wu, C; Zhang, H, 2013) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (8.33) | 29.6817 |
2010's | 40 (83.33) | 24.3611 |
2020's | 4 (8.33) | 2.80 |
Authors | Studies |
---|---|
Leungsuwan, S | 1 |
Hooi, B | 1 |
Myint, KS | 1 |
Xiang, Q | 1 |
Liu, Z | 1 |
Yu, Y | 1 |
Zhang, H | 2 |
Xie, Q | 1 |
Mu, G | 1 |
Zhang, J | 2 |
Cen, X | 1 |
Cui, Y | 1 |
Dong, X | 1 |
Chen, X | 1 |
Tian, Y | 1 |
Wang, J | 1 |
López Medina, JA | 1 |
Simón Frapolli, VJ | 1 |
Tinahones Madueño, FJ | 1 |
Wei, WJ | 1 |
Sun, ZK | 1 |
Shen, CT | 1 |
Qiu, ZL | 1 |
Luo, QY | 1 |
Lin, J | 1 |
Zhuo, Y | 1 |
Zhang, D | 2 |
Park, S | 1 |
Kim, WI | 1 |
Cho, DH | 1 |
Kim, YJ | 1 |
Kim, HS | 1 |
Kim, JH | 1 |
Cha, SK | 1 |
Park, KS | 1 |
Lee, JH | 1 |
Lee, SM | 1 |
Lee, EY | 1 |
Zhu, S | 1 |
Yang, YH | 1 |
Gao, RW | 1 |
Li, R | 1 |
Zou, YZ | 1 |
Feng, L | 2 |
Zhang, B | 1 |
Cho, J | 1 |
Cheung, PP | 1 |
Chen, N | 1 |
Zhang, JB | 1 |
Zhang, Q | 1 |
Zhao, YP | 1 |
Li, LY | 1 |
Liu, LW | 1 |
Yu, F | 1 |
Yu, X | 1 |
Peng, T | 1 |
Tang, KX | 1 |
Koda, R | 1 |
Tsuchida, M | 1 |
Iino, N | 1 |
Narita, I | 1 |
Makita, T | 1 |
Kanzaki, H | 1 |
Onishi, H | 1 |
Ikeda, A | 1 |
Takaki, A | 2 |
Wada, N | 1 |
Takeuchi, Y | 1 |
Yasunaka, T | 1 |
Ikeda, F | 1 |
Shiraha, H | 1 |
Tanaka, Y | 1 |
Nishihara, S | 1 |
Murakawa, K | 1 |
Kitamura, Y | 1 |
Okada, H | 1 |
Sendo, T | 1 |
Kunii, T | 1 |
Iijima, T | 1 |
Jojima, T | 1 |
Shimizu, M | 2 |
Kase, M | 1 |
Sakurai, S | 1 |
Kogai, T | 1 |
Usui, I | 1 |
Aso, Y | 1 |
Qian, YY | 1 |
Dai, ZJ | 1 |
Ruan, LY | 1 |
Pan, YJ | 1 |
Jin, J | 2 |
Shi, MT | 1 |
Zhu, YX | 1 |
Wu, CM | 1 |
Kim, DH | 1 |
Lee, SW | 1 |
Kweon, YO | 1 |
Lee, J | 1 |
Ahn, BC | 1 |
Wu, C | 1 |
Qian, Y | 1 |
Wang, L | 1 |
Gu, X | 1 |
Dai, Z | 1 |
Lucey, JM | 1 |
Hsu, P | 1 |
Ziegler, JB | 1 |
Eguchi, H | 1 |
Tsuruta, M | 1 |
Tani, J | 1 |
Kuwahara, R | 1 |
Hiromatsu, Y | 1 |
Hamnvik, OP | 1 |
Vaidya, A | 1 |
Becker, C | 1 |
Terasaka, T | 1 |
Ueta, E | 1 |
Ebara, H | 1 |
Waseda, K | 1 |
Hanayama, Y | 1 |
Kawabata, T | 1 |
Sugiyama, H | 1 |
Hidani, K | 1 |
Otsuka, F | 1 |
Saeedi, R | 1 |
Jiang, SY | 1 |
Holmes, DT | 1 |
Kendler, DL | 1 |
Iizuka, Y | 1 |
Sakai, H | 1 |
Kobayashi, K | 1 |
Iizuka, K | 1 |
Ito, E | 1 |
Mochizuki, N | 1 |
Asahina, Y | 1 |
Watanabe, M | 1 |
Hirose, K | 1 |
Ubara, Y | 1 |
Hiramatsu, R | 1 |
Sawa, N | 1 |
Hasegawa, E | 1 |
Takaichi, K | 1 |
Ikeda, K | 1 |
Kumada, H | 1 |
Murakami, M | 1 |
Lin, Q | 1 |
Pan, F | 1 |
Hong, F | 1 |
Pan, C | 1 |
Sun, F | 1 |
Wang, G | 1 |
Yang, J | 1 |
Luo, G | 1 |
Ma, H | 1 |
Zhao, Z | 1 |
Wang, Y | 2 |
Zhao, W | 1 |
Zhu, J | 1 |
Huang, F | 1 |
Furusyo, N | 1 |
Ikezaki, H | 1 |
Ogawa, E | 1 |
Hayashi, T | 1 |
Ihara, T | 1 |
Harada, Y | 1 |
Toyoda, K | 1 |
Murata, M | 1 |
Hayashi, J | 1 |
Wang, BF | 1 |
Wang, BY | 1 |
Sun, FR | 1 |
Chen, YS | 1 |
Oh, HM | 1 |
Oh, J | 1 |
Kim, KT | 1 |
Lee, JI | 1 |
Lee, YS | 1 |
Kim, BK | 2 |
Lee, HJ | 1 |
Dan, J | 1 |
Takagi, J | 1 |
Morita, H | 1 |
Ito, K | 1 |
Ohashi, T | 1 |
Hirase, S | 1 |
Ito, T | 1 |
Morishima, T | 1 |
Otake, K | 1 |
Yoneda, M | 1 |
Wei, Z | 1 |
He, JW | 1 |
Fu, WZ | 1 |
Zhang, ZL | 1 |
Perrot, S | 1 |
Aslangul, E | 1 |
Szwebel, T | 1 |
Caillat-Vigneron, N | 1 |
Le Jeunne, C | 1 |
Woodward, CL | 1 |
Hall, AM | 1 |
Williams, IG | 1 |
Madge, S | 1 |
Copas, A | 1 |
Nair, D | 1 |
Edwards, SG | 1 |
Johnson, MA | 1 |
Connolly, JO | 1 |
Wong, T | 1 |
Girgis, CM | 1 |
Ngu, MC | 1 |
Chen, RC | 1 |
Emmett, L | 1 |
Archer, KA | 1 |
Seibel, MJ | 1 |
Kwon, SY | 1 |
Ahn, SY | 1 |
Ko, SY | 1 |
Jang, YM | 1 |
Choi, YH | 1 |
Choe, WH | 1 |
Lee, CH | 1 |
Saidenberg-Kermanac'h, N | 1 |
Souabni, L | 1 |
Prendki, V | 1 |
Prie, D | 1 |
Boissier, MC | 1 |
Pérez-Rivera, AÁ | 1 |
Sáez, P | 1 |
León, E | 1 |
Lozano de León-Naranjo, F | 1 |
Kawate, H | 1 |
Taketomi, A | 1 |
Watanabe, T | 1 |
Nomura, M | 1 |
Kato, M | 1 |
Sakamoto, R | 1 |
Ikegami, T | 1 |
Soejima, Y | 1 |
Maehara, Y | 1 |
Takayanagi, R | 1 |
Haverkort, ME | 1 |
van der Spek, BW | 1 |
Lips, P | 1 |
Slieker, WA | 1 |
ter Heine, R | 1 |
Huitema, AD | 1 |
Bronsveld, W | 1 |
Fabbriciani, G | 1 |
de Socio, GV | 1 |
Massarotti, M | 1 |
Ceriani, R | 1 |
Marasini, B | 1 |
Li, L | 1 |
Dong, GF | 1 |
Zhang, X | 1 |
Xie, YS | 1 |
Sun, XF | 1 |
Zhang, HB | 1 |
Li, XP | 1 |
Xia, WB | 1 |
Xing, XP | 1 |
Meng, XW | 1 |
Powderly, WG | 1 |
Tanaka, M | 1 |
Setoguchi, T | 1 |
Ishidou, Y | 1 |
Arishima, Y | 1 |
Hirotsu, M | 1 |
Saitoh, Y | 1 |
Nakamura, S | 1 |
Kakoi, H | 1 |
Nagano, S | 1 |
Yokouchi, M | 1 |
Kamizono, J | 1 |
Komiya, S | 1 |
Kim, du H | 1 |
Sung, DH | 1 |
Min, YK | 1 |
Shimohata, H | 1 |
Sakai, S | 1 |
Ogawa, Y | 1 |
Hirayama, K | 1 |
Kobayashi, M | 1 |
Parsonage, MJ | 1 |
Wilkins, EG | 1 |
Snowden, N | 1 |
Issa, BG | 1 |
Savage, MW | 1 |
Winston, J | 1 |
Shepp, DH | 1 |
4 reviews available for adenine and Osteomalacia
Article | Year |
---|---|
Hypophosphatemic osteomalacia due to drug-induced Fanconi's syndrome associated with adefovir dipivoxil treatment for hepatitis B.
Topics: Adenine; Bone Diseases, Metabolic; Fanconi Syndrome; Hepatitis B, Chronic; Humans; Hypophosphatemia; | 2014 |
[A case of adefovir dipivoxil induced hypophosphataemic osteomalacia and literature review].
Topics: Adenine; Humans; Hypophosphatemia; Male; Middle Aged; Organophosphonates; Osteomalacia | 2011 |
Osteoporosis and bone health in HIV.
Topics: Absorptiometry, Photon; Acquired Immunodeficiency Syndrome; Adenine; Alcohol Drinking; Anti-HIV Agen | 2012 |
Hypophosphatemic osteomalacia induced by low-dose adefovir therapy: focus on manifestations in the skeletal system and literature review.
Topics: Adenine; Bone and Bones; Dose-Response Relationship, Drug; Humans; Hypophosphatemia; Male; Middle Ag | 2013 |
44 other studies available for adenine and Osteomalacia
Article | Year |
---|---|
Hypophosphatemic Osteomalacia Due to Adefovir-Induced Fanconi Syndrome.
Topics: Adenine; Aged; Alanine; Antiviral Agents; Fanconi Syndrome; Female; Hepatitis C, Chronic; Humans; Hy | 2020 |
Osteomalacia and renal failure due to Fanconi syndrome caused by long-term low-dose Adefovir Dipivoxil: a case report.
Topics: Adenine; Antiviral Agents; Fanconi Syndrome; Hepatitis B, Chronic; Humans; Male; Middle Aged; Organo | 2020 |
Severe hypophosphataemic osteomalacia related to low-dose adefovir dipivoxil therapy in a hepatitis B virus patient.
Topics: Adenine; Antiviral Agents; Hepatitis B virus; Hepatitis B, Chronic; Humans; Hypophosphatemia; Organo | 2021 |
[Adefovir-induced osteomalacia and hypophosphatemia].
Topics: Adenine; Humans; Hypophosphatemia; Organophosphonates; Osteomalacia | 2022 |
Adefovir-Induced Hypophosphatemic Osteomalacia Mimicking Bone Metastases From Primary Hepatocarcinoma.
Topics: Adenine; Bone Neoplasms; Humans; Hypophosphatemia; Liver Neoplasms; Male; Middle Aged; Organophospho | 2017 |
Nephrolithiasis and Osteomalacia associated with adefovir-induced Fanconi syndrome in a patient with hepatitis B.
Topics: Adenine; Antiviral Agents; Fanconi Syndrome; Hepatitis B; Humans; Male; Middle Aged; Nephrolithiasis | 2017 |
Adefovir-induced Fanconi syndrome associated with osteomalacia.
Topics: Adenine; Adult; Bone and Bones; Fanconi Syndrome; Female; Fibroblast Growth Factor-23; Fibroblast Gr | 2018 |
Clinical features of hypophosphatemic osteomalacia induced by long-term low-dose adefovir dipivoxil.
Topics: Adenine; Adult; Aged; Alkaline Phosphatase; Biomarkers; China; Cross-Sectional Studies; Drug Monitor | 2018 |
Osteomalacia Due to Drug-Induced Fanconi Syndrome.
Topics: Adenine; Aged; Antiviral Agents; Fanconi Syndrome; Hepatitis B; Humans; Male; Organophosphonates; Os | 2018 |
Adefovir dipivoxil induced hypophosphatemic osteomalacia in chronic hepatitis B: a comparative study of Chinese and foreign case series.
Topics: Adenine; Adult; Aged; Aged, 80 and over; Antiviral Agents; Asian People; Female; Hepatitis B, Chroni | 2018 |
Hypophosphatemic Osteomalacia Associated with Adefovir-induced Fanconi Syndrome Initially Diagnosed as Diabetic Kidney Disease and Vitamin D Deficiency.
Topics: Adenine; Aged; Antiviral Agents; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Diagnostic Error | 2019 |
[Adefovir Dipivoxil-induced Fanconi's Syndrome and Osteomalacia Following Multiple Bone Fractures in a Patient with Chronic Hepatitis B].
Topics: Adenine; Aged; Carcinoma, Hepatocellular; Fanconi Syndrome; Fractures, Bone; Hepatitis B, Chronic; H | 2019 |
Denosumab improves clinical manifestations of hypophosphatemic osteomalacia by adefovir-induced Fanconi syndrome: a case report.
Topics: Adenine; Adult; Antiviral Agents; Bone Density Conservation Agents; Denosumab; Fanconi Syndrome; Hep | 2019 |
Low-dose adefovir dipivoxil-induced hypophosphatemia osteomalacia in five chronic hepatitis B virus-infected patients. Is low-dose adefovir dipivoxil-induced nephrotoxicity completely reversible?
Topics: Adenine; Aged; Dose-Response Relationship, Drug; Fanconi Syndrome; Female; Hepatitis B, Chronic; Hum | 2019 |
Bone scintigraphic findings of hypophosphatemic osteomalacia associated with adefovir therapy: involvement of lower extremity skeletons.
Topics: Adenine; Bone and Bones; Humans; Hypophosphatemia; Lower Extremity; Male; Middle Aged; Organophospho | 2013 |
Hypophosphatemic osteomalacia and renal Fanconi syndrome induced by low-dose adefovir dipivoxil: a case report and literature review suggesting ethnic predisposition.
Topics: Adenine; Antiviral Agents; Dose-Response Relationship, Drug; Fanconi Syndrome; Humans; Hypophosphate | 2013 |
Tenofovir-related Fanconi's syndrome and osteomalacia in a teenager with HIV.
Topics: Adenine; Adolescent; Anti-HIV Agents; Fanconi Syndrome; HIV Infections; Humans; Male; Organophosphon | 2013 |
Interactive medical case: wasting away.
Topics: Adenine; Adult; Bone Density; Electrolytes; Fanconi Syndrome; Female; Hepatitis B, Chronic; Humans; | 2014 |
Long-term observation of osteomalacia caused by adefovir-induced Fanconi's syndrome.
Topics: Adenine; Antiviral Agents; Fanconi Syndrome; Humans; Male; Middle Aged; Organophosphonates; Osteomal | 2014 |
Fibroblast growth factor 23 is elevated in tenofovir-related hypophosphatemia.
Topics: Adenine; Adult; Anti-HIV Agents; Bone Density; Fanconi Syndrome; Fibroblast Growth Factor-23; Fibrob | 2014 |
[A case of chronic hepatitis B managed with continued adefovir despite treatment-related Fanconi syndrome and osteomalacia].
Topics: Adenine; Fanconi Syndrome; Female; Hepatitis B, Chronic; Humans; Middle Aged; Organophosphonates; Os | 2014 |
[Case report; Fanconi's syndrome and hypophosphatemic osteomalacia associated with adefovir dipivoxil: a case report].
Topics: Adenine; Aged; Antiviral Agents; Fanconi Anemia; Humans; Hypophosphatemia; Organophosphonates; Osteo | 2014 |
[Hypophosphatemic osteomalacia and renal Fanconi syndrome induced by adefovir in a patient with chronic hepatitis B].
Topics: Adenine; Fanconi Syndrome; Hepatitis B, Chronic; Humans; Hypophosphatemia; Organophosphonates; Osteo | 2014 |
[The clinical characteristics of 26 cases of hypophosphatemia osteomalacia misdiagnosed as spondyloarthritis].
Topics: Adenine; Adult; Antirheumatic Agents; Biomarkers; C-Reactive Protein; Fanconi Syndrome; Female; Huma | 2014 |
Predictors of kidney tubular dysfunction induced by adefovir treatment for chronic hepatitis B.
Topics: Adenine; Adult; Age Factors; Aged; Aged, 80 and over; Antiviral Agents; Chi-Square Distribution; Fem | 2015 |
Osteomalacia and Fanconi's syndrome caused by long-term low-dose adefovir dipivoxil.
Topics: Adenine; Antiviral Agents; Calcium; Dose-Response Relationship, Drug; Drug Monitoring; Fanconi Syndr | 2015 |
Osteomalacia as a Cause of Chronic Low Back and Buttock Pain.
Topics: Adenine; Adult; Antiviral Agents; Buttocks; Fractures, Spontaneous; Gait; Humans; Hypophosphatemia; | 2015 |
Pathologic Femoral Neck Fracture Due to Fanconi Syndrome Induced by Adefovir Dipivoxil Therapy for Hepatitis B.
Topics: Adenine; Adult; Antiviral Agents; Fanconi Syndrome; Femoral Neck Fractures; Fractures, Spontaneous; | 2016 |
Urinary β-2 Microglobulin Levels Sensitively Altered in an Osteomalacia Patient Receiving Add-on Adefovir Dipivoxil Therapy for Hepatitis B Virus Infection.
Topics: Adenine; Aged; Antiviral Agents; beta 2-Microglobulin; Female; Hepatitis B, Chronic; Humans; Japan; | 2016 |
Osteomalacia induced by long-term low-dose adefovir dipivoxil: Clinical characteristics and genetic predictors.
Topics: Adenine; Amino Acid Sequence; Case-Control Studies; DNA Mutational Analysis; Dose-Response Relations | 2016 |
Bone pain due to fractures revealing osteomalacia related to tenofovir-induced proximal renal tubular dysfunction in a human immunodeficiency virus-infected patient.
Topics: Adenine; Bone Density Conservation Agents; Fanconi Syndrome; Female; Fractures, Bone; HIV Infections | 2009 |
Tenofovir-associated renal and bone toxicity.
Topics: Adenine; Adult; Anti-HIV Agents; Creatinine; Fanconi Syndrome; Female; Glycosuria; HIV Infections; H | 2009 |
Hypophosphatemic osteomalacia after low-dose adefovir dipivoxil therapy for hepatitis B.
Topics: Adenine; Adult; Antiviral Agents; Hepatitis B, Chronic; Humans; Hypophosphatemia; Magnetic Resonance | 2010 |
[A case of osteomalacia related to adefovir in a patient with chronic hepatitis B].
Topics: Adenine; Aged; Alkaline Phosphatase; Antiviral Agents; Dietary Supplements; DNA, Viral; Hepatitis B, | 2010 |
Normal plasma FGF23 levels kinetic in tenofovir-related hypophosphatemic osteomalacia in an HIV-infected patient with von Recklinghausen disease.
Topics: Acquired Immunodeficiency Syndrome; Adenine; Adult; Anti-HIV Agents; Drug Substitution; Fibroblast G | 2011 |
[HIV infected women with intense bone and muscular pain and general weakness].
Topics: Adenine; Alkynes; Anti-HIV Agents; Benzoxazines; Cyclopropanes; Deoxycytidine; Drug Therapy, Combina | 2011 |
Hypophosphatemic osteomalacia as a long-term complication after liver transplantation.
Topics: Adenine; Aged; Fanconi Syndrome; Female; Humans; Hypophosphatemia; Immunosuppressive Agents; Liver T | 2011 |
Tenofovir-induced Fanconi syndrome and osteomalacia in two HIV-infected patients: role of intracellular tenofovir diphosphate levels and review of the literature.
Topics: Adenine; Adult; Anti-HIV Agents; Diphosphates; Fanconi Syndrome; HIV Infections; Humans; Male; Middl | 2011 |
Adefovir induced hypophosphatemic osteomalacia.
Topics: Adenine; Aged; Humans; Hypophosphatemia; Male; Organophosphonates; Osteomalacia; Radionuclide Imagin | 2011 |
[Adefovir dipivoxil-induced Fanconi syndrome and hypophosphatemic osteomalacia associated with muscular weakness in a patient with chronic hepatitis B].
Topics: Adenine; Antiviral Agents; Bone Diseases, Metabolic; Fanconi Syndrome; Hepatitis B, Chronic; Humans; | 2011 |
Pathological femoral fractures due to osteomalacia associated with adefovir dipivoxil treatment for hepatitis B: a case report.
Topics: Adenine; Antiviral Agents; Arthroplasty, Replacement, Hip; Fanconi Syndrome; Femoral Neck Fractures; | 2012 |
Osteomalacia due to Fanconi's syndrome and renal failure caused by long-term low-dose adefovir dipivoxil.
Topics: Adenine; Antiviral Agents; Fanconi Syndrome; Hepatitis B, Chronic; Humans; Male; Middle Aged; Organo | 2013 |
The development of hypophosphataemic osteomalacia with myopathy in two patients with HIV infection receiving tenofovir therapy.
Topics: Adenine; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Fanconi Syndrome; Female; HIV Infec | 2005 |
Estimating renal function in patients on tenofovir disoproxil fumarate: suggestions for safer use.
Topics: Adenine; Creatinine; Dose-Response Relationship, Drug; Fanconi Syndrome; Glomerular Filtration Rate; | 2006 |